Not applicableStudy completedNCT00069680What this trial is testingGenetic Analysis of Gray Platelet SyndromeWho this might be right forGenetic LinkageMyelofibrosis National Human Genome Research Institute (NHGRI) 123
Large-scale testing (Phase 3)Study completedNCT01349283What this trial is testingImmunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in NewbornsWho this might be right forHepatitis B Crucell Holland BV 1,738
Early research (Phase 1)Study completedNCT04813653What this trial is testingCyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma CellsWho this might be right forMultiple Myeloma in RelapseMultiple Myeloma, Refractory Tel-Aviv Sourasky Medical Center 3
Not applicableStudy completedNCT01505205What this trial is testingStudy on the Evolution of Genes Mutation Related With Gastrointestinal Stromal TumorsWho this might be right forFull Gene Sequences of c-KIT、PDGFRA and DOG1 Are Analyzed With the Screening-sequencing ApproachInvestigate the Characteristics and Variations Associated With the Different Gene Mutations of c-KIT、PDGFRA and DOG1 in GIST Patients Guangxi Medical University 60
Early research (Phase 1)Not Yet RecruitingNCT07211737What this trial is testingNKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or NeuroblastomaWho this might be right forRelapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+1 more Baylor College of Medicine 27
Testing effectiveness (Phase 2)Study completedNCT00634647What this trial is testingSatraplatin and Prednisone to Treat Prostate CancerWho this might be right forProstate CancerGenetic Polymorphism National Cancer Institute (NCI) 24
Not applicableStudy completedNCT02487615What this trial is testingGenetical, Anthropometrical and Biochemical Factors Influencing High Risk Subclinical AtherosclerosisWho this might be right forPrimary Prevention Instituto Dante Pazzanese de Cardiologia 340
Not applicableUnknownNCT00862173What this trial is testingGene-expression Profiles in CNS-metastatic Non-small Cell Lung CancerWho this might be right forBrain DiseaseMetastasisLung Cancer National Institute of Cancerología 120
Not applicableUnknownNCT00006393What this trial is testingGenetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic SclerosisWho this might be right forSystemic Sclerosis National Center for Research Resources (NCRR) 80
Not applicableStudy completedNCT05972408What this trial is testingEvaluation of Prevalence, Molecular and Genetic Backgrounds of Calcium-Based Stones Among Patients With Renal Calcular Disease in Mansoura Urology and Nephrology CenterWho this might be right forRenal Calculi Mansoura University 84
Not applicableUnknownNCT04701229What this trial is testingHaploinsufficiency of the RBM22 and SLU7 Genes in Del(5q) Myelodysplastic SyndromesWho this might be right forMyelodysplastic SyndromesMyelodysplastic Syndrome With Isolated Del(5Q)Myelodysplastic Syndrome With Del(5Q) University Hospital, Brest 100
Post-approval studies (Phase 4)Study completedNCT00381381What this trial is testingThe Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Eisai Korea Inc. 199
Early research (Phase 1)Looking for participantsNCT07216781What this trial is testingSafety and Efficacy of Injectable Klotho Plasmid Gene Therapy in HumansWho this might be right forHealthy Adults Minicircle 24
Testing effectiveness (Phase 2)Study completedNCT02132130What this trial is testingSafety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing LossWho this might be right forUnilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss Novartis Pharmaceuticals 22
Early research (Phase 1)Study completedNCT00058799What this trial is testingTreating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor VaccineWho this might be right forLeukemia Baylor College of Medicine 11
Testing effectiveness (Phase 2)Study completedNCT02317887What this trial is testingStudy of RS1 Ocular Gene Transfer for X-linked RetinoschisisWho this might be right forRetinoschisisX-Linked VegaVect, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT03233204What this trial is testingOlaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+33 more National Cancer Institute (NCI) 6
Not applicableLooking for participantsNCT07326865What this trial is testingHepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric SurgeryWho this might be right forMASLD Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 40
Not applicableWithdrawnNCT06634836What this trial is testingPatient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & BWho this might be right forHemophilia AHemophilia B Pfizer
Testing effectiveness (Phase 2)Study completedNCT01506609What this trial is testingStudy Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer AbbVie 294